Tralokinumab (Anti-IL13) Biosimilar Antibody
- SKU:
- HDBS0129
- Product Type:
- Biosimilar Antibody
- Antibody Type:
- Monoclonal Antibody
- Protein:
- IL-13
- Reactivity:
- Human
- Host Species:
- Chimeric Humanized
- Isotype:
- IgG4
Frequently bought together:
Description
system_update_altDatasheet
Product Name: | Tralokinumab (Anti-IL13) Biosimilar Antibody |
Size: | 100 ug |
Product SKU: | HDBS0129 |
Target: | IL13 |
Host Species: | Homo sapiens |
Reactivity: | Human |
Recommended Dilution: | Flow Cyt 1:100 |
Antibody Type: | Monoclonal |
Buffer: | Lyophilized from sterile PBS, pH 7.4. Normally 5 % - 8% trehalose is added as protectants before lyophilization. Please see Certificate of Analysis for specific instructions. |
Storage & Shipping: | Store at -20°C to -80°C for 12 months in lyophilized form. After reconstitution, if not intended for use within a month, aliquot and store at -80°C (Avoid repeated freezing and thawing).Lyophilized antibodies are shipped at ambient temperature. |
Common Name: | CAT-354, tralokinumab-idrm |
Description: | Anti-IL13(tralokinumab biosimilar) mAb |
Buffer: | Lyophilized from sterile PBS, pH 7.4. Normally 5 % - 8% trehalose is added as protectants before lyophilization. Please see Certificate of Analysis for specific instructions. |
Format: | Powder |
Applications | Flow Cyt |
Antibody Isotype: | IgG4 | Guarantee: | 12 months from date of dispatch |
Background: | Research grade biosimilar. Not for use in therapeutic or diagnostic procedures for humans or animals. |
Synonyms: | Interleukin-13, IL-13 |
Uniprot: | P35225 |